Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000096

Director sold 1,666 shares at $50.05 ($83,383)

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-01 Sale : show line 1 in the form −1,666 $50.05 $83,383 127,833 D
Open-market sales · 1,666 sh · avg $50.05 · $83,383
Loading xslF345X03/wf-form4_163597499893227.xml…